Show simple item record

dc.contributor.authorSalihoglu, Ayse
dc.contributor.authorEskazan, AHMET EMRE
dc.contributor.authorYalniz, Fevzi Firat
dc.contributor.authorBerk, Selin
dc.contributor.authorElverdi, Tuğrul
dc.contributor.authorSoysal, Teoman
dc.contributor.authorErdogan, Isil
dc.date.accessioned2021-03-03T20:29:44Z
dc.date.available2021-03-03T20:29:44Z
dc.date.issued2015
dc.identifier.citationEskazan A. E. , Erdogan I., Berk S., Yalniz F. F. , Elverdi T., Salihoglu A., Soysal T., "Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?", Leukemia & lymphoma, cilt.56, sa.10, ss.2995-6, 2015
dc.identifier.issn1042-8194
dc.identifier.othervv_1032021
dc.identifier.otherav_5a32e79a-6e18-404f-94b7-42a84ed97132
dc.identifier.urihttp://hdl.handle.net/20.500.12627/63411
dc.identifier.urihttps://doi.org/10.3109/10428194.2015.1026819
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleRelapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?
dc.typeMakale
dc.relation.journalLeukemia & lymphoma
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume56
dc.identifier.issue10
dc.identifier.startpage2995
dc.identifier.endpage6
dc.contributor.firstauthorID100191


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record